Page 1651 - Clinical Small Animal Internal Medicine
P. 1651
Index 1589
BHD see Birt–Hogg–Dubé ocular adnexal tumors 1262 arthropod‐borne
VetBooks.ir biceps reflex 735 pancreatitis 604 bacterial infections 844
infections 841–843
pancreatic endocrine tumors 1300
bias 8, 23–24
pericardial disease 279
bile acids (BA) 651–652
bartonellosis 920, 922–923
bile duct tumors 685, 1303–1304, prostatic diseases 1158–1159 bone and joint tumors 1328
1306 soft tissue sarcomas 1334 canine brucellosis 964
biliary cystadenoma 667, 668 sterile nodular panniculitis canine myocardial disease 256,
biliary system 1445–1446 258–259, 264
canine inflammatory liver superficial necrolytic cardiogenic shock 417
disease 700 dermatitis 1492 chronic kidney disease 1165, 1166
feline inflammatory liver see also histology/histopathology ehrlichiosis and
disease 688, 689 bioterrorism anaplasmosis 909–910
hepatobiliary disease 659–660, 664, anthrax 974 endocrine manifestations of
668–670, 669–670 disease monitoring and cancer 1214–1215
bilious vomiting syndrome surveillance 833 feline coronavirus 874
(BVS) 549, 567 tularemia 956 feline immunodeficiency virus 884
bilirubin BIPS see barium‐impregnated feline viral upper respiratory tract
feline inflammatory liver polyethylene spheres disease 888
disease 688 birds 973 fungal infections 846, 991, 994, 996
gallbladder and extrahepatic biliary Birt–Hogg–Dubé (BHD) gallbladder and extrahepatic biliary
ducts 723 syndrome 1317 ducts 723
liver disease 651, 653 BISC see bowenoid in situ carcinoma glomerular disease 1102
metabolic diseases 677, 680 bisphosphonates 1207, 1245 hemotropic Mycoplasma 928
pleural effusion 338, 343 bite wounds hepatobiliary tumors 1305–1306
bilirubinuria 653 diagnosis 1033 intestinal cancers 1289
bilothorax 343 epidemiology 1033 leptospirosis 946
bioethical principles 1561–1564 etiology/pathophysiology 1033 liver disease 653
biofilms 1029–1030 history and clinical signs 1033 Lyme borreliosis 942–943
biologic safety levels (BSL) 900 pleural effusion 340 lymphomas 1233
biopsy prognosis 449, 451–452, 454–457 markers of liver function 649–652
approach to the dermatologic public health implications 1034 meningoencephalitis and
patient 1394–1396 septic shock 424 meningomyelitis 797
autoimmune and immune‐mediated signalment 1033 metabolic bone diseases 1523,
skin disease treatment and 1525–1526
1423–1424, 1426–1430 prognosis 1033–1034 myopathies 812
bone and joint tumors 1329 wound infections 1033–1034 neuromuscular junction diseases
canine inflammatory liver see also venomous snake bites 804, 805
disease 698–699, 699 black widow spider pancreatic endocrine tumors
chronic enteropathies 633–635 envenomation 808 1298, 1300
cirrhosis 708–709 bladder tumors 1307–1308, 1309 pancreatitis 602
endoscopy 510–511, 526–527, 527 blastomycosis 989–990 plasma cell disorders 1243–1245
esophageal and stomach antifungal therapy 1050, 1052 portosystemic shunts and
cancers 1284 diagnosis 989–990, 990 microvascular dysplasia 714,
feline inflammatory liver epidemiology and signalment 989 716, 719
disease 689 etiology/pathophysiology 989 prostatic diseases 1158
glomerular disease 1103 history and clinical signs 989 protozoal and protozoa‐like
intestinal cancers 1289 public health implications 990 infections 841–843, 1004, 1006,
liver disease 656–658 treatment and prognosis 990 1008–1009, 1009, 1011,
lymphomas 1236–1237 blood chemistry/serology 1014–1015
mast cell tumors 1361 acute kidney injury 1091–1093 pulmonary thromboembolism
miscellaneous skin diseases acute poisoning 437 318–319
1496–1497, 1503–1504 antimicrobials 1047 rabies 894
neuromuscular junction apheresis 1369–1372 salmon poisoning disease 914
diseases 805 approach to the cancer seizures and movement
nonmelanoma skin cancers 1355 patient 1201 disorders 762
